To achieve high performance in perovskite solar cells (PSC), the holetransporting layer (HTL) is very important. In this work, we introduce a novel copper-chromium binary metal oxide as the hole-transporting material for PSC application. This low temperature solution-process HTL enables high performance PSC. The energy levels and phase compositions of the binary metal oxide can be modulated with different copper acetylacetonate (y)/ chromium acetylacetonate (z) volume ratios in the reacting solution precursors. X-ray diffraction and X-ray photoelectron spectroscopy show that both mono Cu y O(z ¼ 0) or Cr z O(y ¼ 0) and binary CuCrO 2 and CuCr 2 O 4 phases can be formed. The Cr-terminated polar CuCrO 2 component leads to films with superior wettability and compatibility with perovskite precursor solution, while the formation of high coverage uniform perovskite films is favorable for device fabrication. Unlike copper oxides, the copper-chromium binary metal oxide films have wide band gaps of around 3.1 eV, as well as suitable energy levels for both electron-blocking and hole-transporting. As a result, PSCs with this low-temperature solution processed copper-chromium binary metal oxide HTL have achieved high PCE of 17.19% on glass and 15.53% on flexible PET substrates, which is a significant enhancement over mono-metal oxide based devices.
COVID-19 positive (194) and negative (212) pneumonia patients were selected to analyze bacterial pathogens coinfection. Results showed that 50% of COVID-19 patients were coinfected or carried bacterial pathogens.
Bordetella pertussis
infection rate was significantly higher in positive patients. Consequently, preventions should be taken to control bacterial pathogens coinfection in COVID-19 patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.